- MyIllumina
- Tools
Millions of formalin-fixed paraffin-embedded (FFPE) archival cancer tissue samples provide an enormous and invaluable repository of information for cancer research. These samples hold a wealth of data for the discovery of biomarkers, drug development, and diagnosis and treatment of diseases.
However, the fixation process and storage of FFPE samples frequently leads to nucleic acid degradation and base modification. Until recently, degraded DNA from FFPE samples generally resulted in poor performance for genotyping studies using the Infinium HD Assay, as it was inefficiently amplified in the whole-genome amplification step.
To overcome this problem, Illumina has developed a FFPE sample restoration solution that provides a simple workflow to QC samples, repair damaged DNA, and achieve high-quality data using the Infinium HD Assay.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.